Skip to content

Investigation to explore whether there is a synergistic effect between nicotine replacement therapy and guided bodyscanning on cigarette cravings and withdrawal symptoms

Investigation to explore whether there is a synergistic effect between nicotine replacement therapy and guided bodyscanning on cigarette cravings and withdrawal symptoms

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN52104724
Enrollment
72
Registered
2008-10-27
Start date
2009-01-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking cessation Mental and Behavioural Disorders Mental and behavioural disorders due to use of tobacco

Interventions

Participants will be randomly allocated to receive either 1. Active nicotine patch plus: 1.1. Guided bodyscanning audio 1.2. Passive control audio (a natural history text reading) 2. Placebo patch p

Sponsors

University of Surrey (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Smokers 2. Aged 18 to 65 years, either sex 3. Consume at least 10 cigarettes a day, and have done for at least the last three consecutive years

Exclusion criteria

Exclusion criteria: 1. Receiving treatment for mental health problems 2. Pregnant 3. Currently trying to conceive

Design outcomes

Primary

MeasureTime frame
Strength of desire to smoke and tobacco withdrawal symptoms will be measured using the self-report 7-point Mood and Physical Symptoms Scale (MPSS), whereby 1 = 'not at all', 4 = 'somewhat' and 7 = 'extremely'. All ratings will be made on a pre-programmed palmtop computer which will prompt participants to ratings at: 1. 10 am: Single set of ratings in the presence of the researcher 2. 11 am: Single set of ratings in your natural environment 3. 12 pm: Multiple rating at the intervals detailed below 4. Between 1 pm and 4 pm (if necessary): Multiple ratings at the intervals detailed below: Rating 1 (just before audio) Audio (10 minutes) Rating 2 (just after audio) Rating 3 (5 minutes after audio) Rating 4 (20 minutes after audio) Rating 5 (30 minutes after audio)

Secondary

MeasureTime frame
No secondary outcome measures

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026